ELK3 and breast carcinoma: In previous studies, ELK3 upregulation resulted in increased metastatic behaviour of breast cancer and liver cancer stem cells by enhancing cell migration and invasion, whereas its suppression led to a reversal of the epithelial-mesenchymal transition in breast cancer cells [45–47].